Loading clinical trials...

Cardiac Performance System Data Collection Study - Minnesota | Clinical Trials | Clareo Health

RECRUITING

Cardiac Performance System Data Collection Study - Minnesota

NCT06149143•Sensydia Corporation

Summary

Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)

Detailed Description

Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)

Eligibility

Age

22 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Ability to provide written informed consent
•22 years of age or older
•Referred for cardiac catheterization for reasons including heart failure, evaluation before transplant, pulmonary hypertension, shortness of breath, valvular disease, etc.

Exclusion Criteria

•Previous Heart Transplant
•Presence of Left Ventricular Assist Device
•Presence of a Holter monitor or any other electrical leads on the chest at the time of sensor placement
•Surgical scars/wounds/bandages/ports at the site of sensor placement

Locations (1)

University of Minnesota

Minneapolis, Minnesota, United States

Key Dates

Start Date

October 3, 2023

Primary Completion Date

June 30, 2024

Completion Date

June 30, 2024

Last Updated

April 17, 2024

Enrollment

ESTIMATED participants

Conditions

Cardiac Disease

Interventions

Cardiac Performance System (NSR)

DEVICE

Contacts

Sensydia

CONTACT

6618774670 info[@]sensydia.com

Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery

NCT07032792

Cardiac DiseaseSurgery+1 more

View study

RECRUITING

The Clinical Value of Deep Learning-Based Reconstruction Techniques in Cardiac MRI Scanning

NCT07274436

Cardiac Disease

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 17, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Cardiac Performance System Data Collection Study - Minnesota

Inclusion Criteria

Exclusion Criteria

Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery

The Clinical Value of Deep Learning-Based Reconstruction Techniques in Cardiac MRI Scanning

A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening

Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging

Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART

Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease